ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Bausch and Lomb Corporation

Bausch and Lomb Corporation (BLCO)

20,61
-0,43
(-2,04%)
Geschlossen 21 Juni 10:12PM

Bausch and Lomb Corporation (BLCO) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
20,61
( -2,04% )
Gebot
20,61
Fragen
21,60
Volumen
398
21,05 Tagesbereich 21,05
15,73 52-Wochen-Bereich 25,70
Marktkapitalisierung
Handelsende
21,04
Handelsbeginn
21,05
Letzte Trade
98
@
20.61
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
$ 456.791
Ausgegebene Aktien
356.536.358
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-24,12
Gewinn pro Aktie (EPS)
-0,62
Erlöse (LTM)
5,21B
Nettogewinn (LTM)
-219M

Über Bausch and Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision C... Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc. Mehr anzeigen

Sektor
Healthcare
Branche
Medical Equipment & Supplies
Website
Hauptsitz
Vaughan, Canada
Gegründet
2026
Bausch and Lomb Corporation is listed in the Healthcare sector of the Toronto Börse with ticker BLCO. The last closing price for Bausch and Lomb was $21,04. Over the last year, Bausch and Lomb shares have traded in a share price range of $ 15,73 to $ 25,70.

Bausch and Lomb currently has 356.536.358 shares in issue. The market capitalisation of Bausch and Lomb is $7,35 billion. Bausch and Lomb has a price to earnings ratio (PE ratio) of -24.12.

BLCO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.61-2.8746465598521.2221.4720.69102321.01897732CS
4-1.75-7.8264758497322.3622.3620.25157021.26038302CS
12-1.04-4.8036951501221.6523.4620.25202421.8203467CS
26-1.45-6.5729827742522.0625.720.25226722.60071546CS
524.7529.949558638115.8625.715.73230421.2937706CS
156-5.44-20.882917466426.0529.3714.56325322.01652805CS
260-3.39-14.1252429.3714.56380021.80122631CS

BLCO - Frequently Asked Questions (FAQ)

What is the current Bausch and Lomb Corporation share price?
The current share price of Bausch and Lomb Corporation is $ 20,61
How many Bausch and Lomb Corporation shares are in issue?
Bausch and Lomb Corporation has 356.536.358 shares in issue
What is the market cap of Bausch and Lomb Corporation?
The market capitalisation of Bausch and Lomb Corporation is CAD 7,35B
What is the 1 year trading range for Bausch and Lomb Corporation share price?
Bausch and Lomb Corporation has traded in the range of $ 15,73 to $ 25,70 during the past year
What is the PE ratio of Bausch and Lomb Corporation?
The price to earnings ratio of Bausch and Lomb Corporation is -24,12
What is the cash to sales ratio of Bausch and Lomb Corporation?
The cash to sales ratio of Bausch and Lomb Corporation is 1,03
What is the registered address of Bausch and Lomb Corporation?
The registered address for Bausch and Lomb Corporation is 520 Applewood Crescent, Vaughan, Ontario, L4K 4B4
What is the Bausch and Lomb Corporation website address?
The website address for Bausch and Lomb Corporation is www.bausch.com
Which industry sector does Bausch and Lomb Corporation operate in?
Bausch and Lomb Corporation operates in the Medical Equipment & Supplies sector

BLCO Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen